Medical Advertising: Criminal Fraud Convictions for Doctor, Clinic Owner, and Agency in Misleading Stem Cell Campaign

Medical Advertising: Criminal Fraud Convictions for Doctor, Clinic Owner, and Agency in Misleading Stem Cell Campaign

In a landmark ruling delivered by the Criminal Court in 2025, three parties—a licensed physician, the owner of a private medical clinic, and the advertising agency they hired—were found guilty of criminal fraud under Section 341 of the Penal Code. The case centered on misleading online advertisements for stem cell therapy and anti-aging treatments. All three received prison sentences and fines, marking one of the strongest judicial responses to date against false medical advertising in Thailand.

Summary of the Court’s Findings:

The court determined that the defendants jointly created and published advertisements on Facebook and Line that contained the following false or exaggerated claims:

• “Stem cell therapy can cure diabetes, high blood pressure, and knee degeneration permanently.”
• “100 % success rate with no side effects”
• “Patients will look 10–20 years younger after one treatment.”

The advertisements used before-and-after photos of patients (without proper consent or medical evidence) and included fabricated testimonials. When patients paid between 280,000 and 650,000 baht per course, they received only standard vitamin infusions or platelet-rich plasma (PRP), not the promised stem cell therapy.

The court ruled that:

• The physician knowingly allowed his name and medical license to be used in the deceptive ads
• The clinic owner approved and paid for the campaign despite knowing the claims were impossible to fulfill
• The advertising agency designed the content, posted it, and collected the advertising fee, fully aware of the falsehoods

All three were convicted of fraud by deception, causing property loss to the victims (Section 341 Penal Code) and of violating the Medical Profession Act B.E. 2525 (1982) (using a physician’s name in misleading advertising) and the Consumer Protection Act B.E. 2522 (1979) (false advertising).

Sentences Imposed:

• The doctor: 2 years imprisonment (suspended for 4 years) + 200,000 baht fine
• The clinic owner: 2 years 6 months imprisonment (suspended for 5 years) + 300,000 baht fine
• The agency director: 2 years imprisonment (suspended for 4 years) + 200,000 baht fine

The court also ordered all three defendants to pay compensation totaling 4.2 million baht to the 12 victim-patients who filed complaints.

Relevant Laws Applied in the Judgment:

1. Penal Code, Section 341 – Fraud by deception causing property loss (maximum 3 years imprisonment and/or fine)
2. Medical Profession Act B.E. 2525 (1982), Section 27 – Prohibits physicians from allowing their name to be used in false or exaggerated advertising.
3. Consumer Protection Act B.E. 2522 (1979), Section 22 – Prohibits false, deceptive, or exaggerated advertising that may cause misunderstanding
4. Medical Facilities Act B.E. 2541 (1998) – The clinic’s license was placed under review for allowing unethical advertising.

How These Laws Interact:

• The Penal Code provides criminal punishment for the actual financial harm caused to patients.
• The Medical Profession Act targets the doctor’s ethical breach and can lead to license suspension or revocation by the Medical Council.
• The Consumer Protection Act allows the Consumer Protection Board to impose additional administrative fines and bans on advertising.
• When all three laws are applied together, the court can impose both imprisonment and compensation, while the professional council and government agencies handle long-term sanctions (license loss, business closure)

Key Takeaways:

• Shared Criminal Liability: For the first time, the entire chain—physician, clinic owner, and advertising agency—was held jointly criminally responsible for fraudulent medical ads.
• No “Ignorance” Defense: Doctors cannot claim innocence by saying they merely lent their name; agencies cannot hide behind “client instructions” if they know claims are false.
• Severe Consequences: Beyond fines and suspended sentences, defendants face civil compensation and potential professional sanctions (e.g., license revocation).
• Patient Protection Strengthened: Victims can pursue remedies through criminal complaints, Consumer Protection Board filings, or Medical Council reports.
• Deterrent Effect: The ruling signals stricter enforcement against exaggerated health claims, especially in high-value treatments like stem cells and anti-aging therapies.

Significance of the Ruling:

This judgment sends a clear message that misleading medical advertising is not merely an ethical violation but can constitute criminal fraud when it induces financial loss. Patients who have paid for treatments after seeing similar online ads are strongly encouraged to retain evidence (screenshots, receipts, chat records) and file complaints with the Consumer Protection Board, the Medical Council, and/or the inquiry officer.

Author: Panisa Suwanmatajarn, Managing Partner.

Other Articles

• Proposed Amendments to Anti-Corruption Legislation to Align with OECD Standards
• Notification of the Competent Officer on Exchange Control (No. 38) — Draft Amendment
• Thailand’s Proposed Updates to the Non-Preferential Certificate of Origin Framework for Exports to the United States and the European Union
• Thailand’s Expanding Trade Network: Key Updates on FTAs with Partner Countries
• Thailand FDA — Proposed Food Labelling Rules for Prepackaged Foods
• U.S. Tariff Developments Post Supreme Court Ruling